Amicus Therapeutics spins off genetic medicine unit in $600M SPAC deal
September 29, 2021 at 15:02 PM EDT
Amicus is spinning off part of its gene therapy business a year after establishing its gene therapy research center in Philadelphia.
Photography by Christophe Tomatis